# Charlotte's Web Holdings, Inc.: financial statements, quarterly

CWBHF · OTC · CIK 1750155 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cwbhf.md) · [Financials](/companies/cwbhf/financials.md) · [Filings](/companies/cwbhf/filings.md) · [Insiders](/companies/cwbhf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cwbhf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [14.3](/filings/0001750155-24-000071.md) | [15.8 d](/filings/0001750155-25-000006.md) | [12.1](/filings/0001750155-25-000031.md) | [12.3](/filings/0001750155-25-000054.md) | [12.6](/filings/0001750155-25-000079.md) | [12.7 d](/filings/0001750155-26-000029.md) | [12.3](/filings/0001750155-26-000077.md) | [12.8](/filings/0001750155-26-000117.md) | [11.5](/filings/0001750155-25-000079.md) | [13.3 d](/filings/0001750155-26-000029.md) | [11.2](/filings/0001750155-26-000077.md) | [10.9](/filings/0001750155-26-000117.md) |
| Cost of revenue | $m | [6.4](/filings/0001750155-24-000071.md) | [7.0 d](/filings/0001750155-25-000006.md) | [5.2](/filings/0001750155-25-000031.md) | [9.7](/filings/0001750155-25-000054.md) | [5.9](/filings/0001750155-25-000079.md) | [7.6 d](/filings/0001750155-26-000029.md) | [6.0](/filings/0001750155-26-000077.md) | [6.8](/filings/0001750155-26-000117.md) | [7.0](/filings/0001750155-25-000079.md) | [8.3 d](/filings/0001750155-26-000029.md) | [6.0](/filings/0001750155-26-000077.md) | [5.7](/filings/0001750155-26-000117.md) |
| Gross profit | $m | [7.9](/filings/0001750155-24-000071.md) | [8.8 d](/filings/0001750155-25-000006.md) | [6.9](/filings/0001750155-25-000031.md) | [2.6](/filings/0001750155-25-000054.md) | [6.7](/filings/0001750155-25-000079.md) | [5.1 d](/filings/0001750155-26-000029.md) | [6.2](/filings/0001750155-26-000077.md) | [6.0](/filings/0001750155-26-000117.md) | [4.5](/filings/0001750155-25-000079.md) | [5.0 d](/filings/0001750155-26-000029.md) | [5.2](/filings/0001750155-26-000077.md) | [5.2](/filings/0001750155-26-000117.md) |
| Selling, general and administrative | $m | [19.9](/filings/0001750155-24-000071.md) | [18.6 d](/filings/0001750155-25-000006.md) | [15.3](/filings/0001750155-25-000031.md) | [14.7](/filings/0001750155-25-000054.md) | [12.7](/filings/0001750155-25-000079.md) | [10.5 d](/filings/0001750155-26-000029.md) | [11.6](/filings/0001750155-26-000077.md) | [10.1](/filings/0001750155-26-000117.md) | [9.7](/filings/0001750155-25-000079.md) | [10.6 d](/filings/0001750155-26-000029.md) | [9.5](/filings/0001750155-26-000077.md) | [9.5](/filings/0001750155-26-000117.md) |
| Operating income | $m | [(12.0)](/filings/0001750155-24-000071.md) | [(10.3) d](/filings/0001750155-25-000006.md) | [(8.4)](/filings/0001750155-25-000031.md) | [(12.1)](/filings/0001750155-25-000054.md) | [(6.0)](/filings/0001750155-25-000079.md) | [(5.5) d](/filings/0001750155-26-000029.md) | [(5.3)](/filings/0001750155-26-000077.md) | [(4.1)](/filings/0001750155-26-000117.md) | [(5.3)](/filings/0001750155-25-000079.md) | [(5.6) d](/filings/0001750155-26-000029.md) | [(4.3)](/filings/0001750155-26-000077.md) | [(4.4)](/filings/0001750155-26-000117.md) |
| Income tax | $m | [0.0](/filings/0001750155-24-000071.md) | [0.5 d](/filings/0001750155-25-000006.md) | [0.0](/filings/0001750155-25-000031.md) | [0.0](/filings/0001750155-25-000054.md) | [0.0](/filings/0001750155-25-000079.md) | [(0.0) d](/filings/0001750155-26-000029.md) | [0.0](/filings/0001750155-26-000077.md) | [(0.0)](/filings/0001750155-26-000117.md) | [(0.0)](/filings/0001750155-25-000079.md) | [(0.0) d](/filings/0001750155-26-000029.md) | [(0.0)](/filings/0001750155-26-000077.md) | [0.0](/filings/0001750155-26-000117.md) |
| Net income | $m | [(15.1)](/filings/0001750155-24-000071.md) | [(8.6) d](/filings/0001750155-25-000006.md) | [(9.6)](/filings/0001750155-25-000079.md) | [(11.1)](/filings/0001750155-25-000079.md) | [(5.8)](/filings/0001750155-25-000079.md) | [(3.4) d](/filings/0001750155-26-000029.md) | [(6.2)](/filings/0001750155-26-000117.md) | [(6.3)](/filings/0001750155-26-000117.md) | [(5.8)](/filings/0001750155-25-000079.md) | [(11.4) d](/filings/0001750155-26-000029.md) | [(13.1)](/filings/0001750155-26-000117.md) | [(4.1)](/filings/0001750155-26-000117.md) |
| Diluted EPS | $ per share | [(0.10)](/filings/0001750155-24-000071.md) | not reported | [(0.06)](/filings/0001750155-25-000031.md) | [(0.07)](/filings/0001750155-25-000054.md) | [(0.04)](/filings/0001750155-25-000079.md) | not reported | [(0.04)](/filings/0001750155-26-000077.md) | [(0.04)](/filings/0001750155-26-000117.md) | [(0.04)](/filings/0001750155-25-000079.md) | not reported | [(0.08)](/filings/0001750155-26-000077.md) | [(0.02)](/filings/0001750155-26-000117.md) |
| Basic EPS | $ per share | [(0.10)](/filings/0001750155-24-000071.md) | not reported | [(0.06)](/filings/0001750155-25-000031.md) | [(0.07)](/filings/0001750155-25-000054.md) | [(0.04)](/filings/0001750155-25-000079.md) | not reported | [(0.04)](/filings/0001750155-26-000077.md) | [(0.04)](/filings/0001750155-26-000117.md) | [(0.04)](/filings/0001750155-25-000079.md) | not reported | [(0.08)](/filings/0001750155-26-000077.md) | [(0.02)](/filings/0001750155-26-000117.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [51.0](/filings/0001750155-23-000083.md) | [47.8](/filings/0001750155-25-000006.md) | [38.5](/filings/0001750155-24-000044.md) | [32.5](/filings/0001750155-24-000059.md) | [24.6](/filings/0001750155-24-000071.md) | [22.6](/filings/0001750155-26-000029.md) | [19.4](/filings/0001750155-25-000031.md) | [15.3](/filings/0001750155-25-000054.md) | [9.8](/filings/0001750155-25-000079.md) | [8.0](/filings/0001750155-26-000117.md) | [5.2](/filings/0001750155-26-000077.md) | [14.0](/filings/0001750155-26-000117.md) |
| Current assets | $m | [83.7](/filings/0001750155-23-000083.md) | [78.2](/filings/0001750155-25-000006.md) | [68.3](/filings/0001750155-24-000044.md) | [56.9](/filings/0001750155-24-000059.md) | [50.0](/filings/0001750155-24-000071.md) | [47.0](/filings/0001750155-26-000029.md) | [44.0](/filings/0001750155-25-000031.md) | [39.7](/filings/0001750155-25-000054.md) | [34.5](/filings/0001750155-25-000079.md) | [30.4](/filings/0001750155-26-000117.md) | [27.1](/filings/0001750155-26-000077.md) | [34.6](/filings/0001750155-26-000117.md) |
| Total assets | $m | [164](/filings/0001750155-23-000083.md) | [153](/filings/0001750155-25-000006.md) | [142](/filings/0001750155-24-000044.md) | [130](/filings/0001750155-24-000059.md) | [120](/filings/0001750155-24-000071.md) | [113](/filings/0001750155-26-000029.md) | [108](/filings/0001750155-25-000031.md) | [88.0](/filings/0001750155-25-000054.md) | [81.6](/filings/0001750155-25-000079.md) | [75.3](/filings/0001750155-26-000117.md) | [70.7](/filings/0001750155-26-000077.md) | [76.4](/filings/0001750155-26-000117.md) |
| Current liabilities | $m | [24.8](/filings/0001750155-23-000083.md) | [23.6](/filings/0001750155-25-000006.md) | [19.6](/filings/0001750155-24-000044.md) | [18.5](/filings/0001750155-24-000059.md) | [16.5](/filings/0001750155-24-000071.md) | [15.9](/filings/0001750155-26-000029.md) | [18.5](/filings/0001750155-25-000031.md) | [10.4](/filings/0001750155-25-000054.md) | [8.9](/filings/0001750155-25-000079.md) | [8.7](/filings/0001750155-26-000117.md) | [8.1](/filings/0001750155-26-000077.md) | [8.3](/filings/0001750155-26-000117.md) |
| Total liabilities | $m | [100](/filings/0001750155-23-000083.md) | [97.0](/filings/0001750155-25-000006.md) | [95.1](/filings/0001750155-24-000044.md) | [94.0](/filings/0001750155-24-000059.md) | [89.4](/filings/0001750155-24-000071.md) | [86.4](/filings/0001750155-26-000029.md) | [87.0](/filings/0001750155-25-000031.md) | [73.0](/filings/0001750155-25-000054.md) | [72.4](/filings/0001750155-25-000079.md) | [77.3](/filings/0001750155-26-000117.md) | [85.7](/filings/0001750155-26-000077.md) | [20.3](/filings/0001750155-26-000117.md) |
| Shareholders' equity | $m | [63.7](/filings/0001750155-24-000071.md) | [55.6](/filings/0001750155-26-000029.md) | [46.7](/filings/0001750155-25-000079.md) | [35.8](/filings/0001750155-25-000079.md) | [30.2](/filings/0001750155-25-000079.md) | [27.1](/filings/0001750155-26-000117.md) | [21.1](/filings/0001750155-26-000117.md) | [14.9](/filings/0001750155-26-000117.md) | [9.2](/filings/0001750155-25-000079.md) | [(2.0)](/filings/0001750155-26-000117.md) | [(15.0)](/filings/0001750155-26-000117.md) | [56.1](/filings/0001750155-26-000117.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(7,840) d](/filings/0001750155-24-000071.md) | [(2,537) d](/filings/0001750155-25-000006.md) | [(7,179)](/filings/0001750155-25-000031.md) | [(4,704) d](/filings/0001750155-25-000054.md) | [(7,586) d](/filings/0001750155-25-000079.md) | [(1,792) d](/filings/0001750155-26-000029.md) | [(2,768)](/filings/0001750155-26-000077.md) | [(4,018) d](/filings/0001750155-26-000117.md) | [(5,460) d](/filings/0001750155-25-000079.md) | [(1,875) d](/filings/0001750155-26-000029.md) | [(2,779)](/filings/0001750155-26-000077.md) | [(926) d](/filings/0001750155-26-000117.md) |
| Capital expenditure | $k | [2,828 d](/filings/0001750155-24-000071.md) | [676 d](/filings/0001750155-25-000006.md) | [2,060](/filings/0001750155-25-000031.md) | [1,256 d](/filings/0001750155-25-000054.md) | [315 d](/filings/0001750155-25-000079.md) | [220 d](/filings/0001750155-26-000029.md) | [521](/filings/0001750155-26-000077.md) | [131 d](/filings/0001750155-26-000117.md) | [(2.0) d](/filings/0001750155-25-000079.md) | [(101) d](/filings/0001750155-26-000029.md) | [21.0](/filings/0001750155-26-000077.md) | [29.0 d](/filings/0001750155-26-000117.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [145](/filings/0001750155-23-000083.md) | [152](/filings/0001750155-24-000044.md) | [153](/filings/0001750155-24-000059.md) | [153](/filings/0001750155-24-000071.md) | [156](/filings/0001750155-25-000031.md) | [157](/filings/0001750155-25-000054.md) | [157](/filings/0001750155-25-000079.md) | [158](/filings/0001750155-26-000077.md) | [159](/filings/0001750155-26-000117.md) | [159](/filings/0001750155-25-000079.md) | [160](/filings/0001750155-26-000077.md) | [199](/filings/0001750155-26-000117.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 271,291,529 at 2026-08-11, from the cover of the [10-Q filed 2026-08-13](/filings/0001750155-26-000117.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.